Journey Medical Corporation

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.

Journey Medical Corporation focuses on providing effective solutions for skin health, specifically in areas such as acne and other skin conditions. This is self-described as a commitment to improving patient outcomes.

NASDAQ:DERM

Journey Medical Corporation

Last Close

5.20

25/09 14:37

Market Cap

110.27M

Beta: -

Volume Today

7.16K

Avg: 14.03K

PE Ratio

−6.91

PFCF: −14.72

Analysis Not Available